PRTGPORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 3.43 $ 0.23 (7.3 %)    

Tuesday, 10-Sep-2024 10:04:18 EDT
QQQ $ 468.98 $ 0.35 (0.07 %)
DIA $ 409.07 $ -0.39 (-0.1 %)
SPY $ 554.88 $ -0.11 (-0.02 %)
TLT $ 100.26 $ -0.11 (-0.11 %)
GLD $ 235.54 $ 0.90 (0.38 %)
$ 3.38
$ 2.84 x 200
-- x --
-- - --
$ 2.10 - $ 60.00
76,179
na
3.34M
$ 36.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 portage-biotech-continues-to-explore-strategic-alternatives-including-potential-sale-merger-restructuring-or-company-wind-down

- Reuters 

 portage-biotech-q2-eps-158-up-from-669-yoy

Portage Biotech (NASDAQ:PRTG) reported quarterly losses of $(1.58) per share. This is a 76.38 percent increase over losses of $...

 portage-biotech-reports-fy24-net-result-of-754m-vs-1047m-last-year-says-discontinuing-inkt-clinical-trial-for-port-2-continues-to-explore-strategic-alternatives-including-restructurings-both-in-and-out-of-court

The decrease was primarily due to lower non-cash losses on impairment related to the Company's identifiable intangible asse...

 why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION